Infective endocarditis following tumor necrosis factor-α antagonist therapy for management of psoriatic erythroderma: a case report

BACKGROUND: The introduction of biological agents, such as infliximab, which act against tumor necrosis factor-α was a major advance for the treatment of an increasing number of chronic diseases. Tumor necrosis factor-α antagonists represent a major therapeutic advance for the management of chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizuno, Takuro, Kiyosawa, Jun, Fukuda, Akihiro, Watanabe, Seiji, Kurose, Nozomu, Nojima, Takayuki, Kanda, Tsugiyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299640/
https://www.ncbi.nlm.nih.gov/pubmed/28179019
http://dx.doi.org/10.1186/s13256-016-1130-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299640/
https://www.ncbi.nlm.nih.gov/pubmed/28179019
http://dx.doi.org/10.1186/s13256-016-1130-1

Ejemplares similares